BABA vs NVVE

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

NVVE exhibits extreme financial distress, anchored by a Piotroski F-Score of 1/9, indicating critical weakness across nearly all fundamental health dimensions. The company suffers from negative equity (Price/Book of -0.27) and catastrophic profitability metrics, including an ROE of -5084.87% and negative gross margins. A devastating 98.3% decline in share price over the last year, coupled with a 52-week high of $142.00 versus a current price of $0.67, suggests a total collapse in investor confidence. The lack of an Altman Z-Score and Graham Number further confirms that the company does not meet the minimum thresholds for solvency or defensive valuation.